Cutaneous and Mucocutaneous Leishmaniasis in Travelers and Migrants: A 20-year GeoSentinel Surveillance Network Analysis.
Cutaneous leishmaniasis (CL) may be emerging among international travelers and migrants. Limited data exist on mucocutaneous leishmaniasis (MCL) in travelers. We describe the epidemiology of travel-associated CL and MCL among international travelers and immigrants over a 20-year period through descriptive analysis of GeoSentinel data. Demographic and travel-related data on returned international travelers diagnosed with CL or MCL at a GeoSentinel Surveillance Network site between September 1, 1997 and August 31, 2017 were analyzed. Nine-hundred, fifty-five returned travelers or migrants were diagnosed with travel-acquired CL (n=916) or MCL during the study period, of whom 10% (n=97) were migrants. For the 858 non-migrant travelers, common source countries were Bolivia (n=156, 18.2%) and Costa Rica (n=97, 11.3%), while for migrants, they were Syria (n=34, 35%) and Afghanistan (n=22, 22.7%). Ninety-nine travelers (10%) acquired their disease on trips of ≤2 weeks. Of 274 cases for which species identification was available, Leishmania Viannia braziliensis was the most well represented strain (n=117, 42.7%), followed by L. major (n=40, 14.6%), and L. V. panamensis (n=38, 13.9%). Forty cases of MCL occurred, most commonly in tourists (n=29, 72.5%) and from Bolivia (n=18, 45%). 10% of MCL cases were acquired in the Old World. Amongst GeoSentinel reporting sites, CL is predominantly a disease of tourists traveling mostly to countries in Central and South America such as Bolivia where risk of acquiring L. V. braziliensis and subsequent MCL is high. The finding that some travelers acquired leishmaniasis on trips of short duration challenges the common notion that CL is a disease of prolonged travel. Migrants from areas of conflict and political instability, such as Afghanistan and Syria, were well represented, suggesting that as mass migration of refugees continues, CL will be increasingly encountered in intake countries.